PD-L1 is frequently expressed in many tumors to suppress anti-tumor immunity mediated by PD-1 positive tumor-infiltrating cytotoxic T lymphocytes through the PD-L1/PD-1 ligation [1]. This evidence concerns the gene CD274 and neoplasm.